PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes
-
Published:2024-02
Issue:
Volume:Volume 17
Page:857-864
-
ISSN:1178-7007
-
Container-title:Diabetes, Metabolic Syndrome and Obesity
-
language:en
-
Short-container-title:DMSO
Author:
Penaforte-Saboia JaquellyneORCID,
Couri Carlos,
Albuquerque Natasha,
Linard Lana,
Araújo DanielORCID,
de Oliveira Sherida,
Gomes Thisciane,
Pinheiro MarceloORCID,
Castelo Maria,
Fernandes VirgíniaORCID,
Montenegro Júnior RenanORCID
Publisher
Informa UK Limited
Reference50 articles.
1. International Diabetes Federation. IDF diabetes atlas. Brussels: International Diabetes Federation; 2019. Available from: https://diabetesatlas.org/idfawp/resourcefiles/2021/07/IDF_Atlas_10th_Edition_2021.pdf. Accessed February 22, 2022.
2. Year in Diabetes 2012: The Diabetes Tsunami
3. Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method
4. Type 1 diabetes: new perspectives on disease pathogenesis and treatment
5. Birth and coming of age of islet autoantibodies